Recombinant Influenza vaccine is more effective than standard inactivated vaccine

News Hour:

Although the development of the inactivated influenza vaccine (IIV) was a major public health achievement, the current vaccine has clear limitations: effectiveness varies from year to year, and egg protein is troublesome for some. Investigators conducted an industry-supported multicenter comparison of safety and efficacy of two vaccines during the 2014-2015 season.

They compared a new, quadrivalent influenza vaccine (RIV4) containing 45 μg each of four recombinant influenza hemagglutinin (HA) proteins produced in serum-free medium with an FDA-approved IIV containing 15 μg each of the same four HA proteins. The study population enrolled was 9003 patients aged 50 or older who were not acutely ill or receiving immunosuppressive therapy.

The incidence of confirmed influenza illness was 30% lower in the RIV4 recipients (2.2%) than in the IIV recipients (3.2%). The higher efficacy was solely against influenza A (36%) as opposed to influenza B (none) and endured throughout the influenza season. There were no notable differences in adverse events between the two study groups.


This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]nline
No Comments

Join Epidemiology Congress 2019

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Sacred Games exposes Rajshri Deshpande nude [video]
Banglalink and Facebook jointly launched the campaign "Learn More, be More"
SRK as Satyajit Ray! Here is the truth behind the poster
Anurag Kashyap shoots Kubra Saith 7 times nude and made her cry for frontal nudity scene [Video]
Huawei introduces EMI facilities for smartphone purchase in Bangladesh
World Heart Day rally organized in Guwahati


News of the Month

Scroll Up
%d bloggers like this: